Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. Subcutaneous nerve stimulation (ScNS) damages the stellate ganglion and improves rhythm control of atrial fibrillation (AF) in ambulatory dogs. Objective: To test the hypothesis that thoracic ScNS can improve rate control in persistent AF. Methods:

  2. Subcutaneous nerve stimulation (ScNS) damages the stellate ganglion and improves rhythm control of atrial fibrillation (AF) in ambulatory dogs.

  3. Subcutaneous nerve stimulation (ScNS) remodels the stellate ganglion and reduces stellate ganglion nerve activity (SGNA) in dogs. Acute myocardial infarction (MI) increases SGNA through nerve sprouting.

  4. 2 Background: Subcutaneous nerve stimulation (ScNS) damages the stellate ganglion and 3 improves rhythm control of atrial fibrillation (AF) in ambulatory dogs. 4 Objective: To test the hypothesis that thoracic ScNS can improve rate control in persistent AF.

  5. Objective. To test the hypothesis that chronic thoracic subcutaneous nerve stimulation (ScNS) could reduce SG nerve activity (SGNA) and control paroxysmal atrial tachycardia (PAT). Methods. We performed thoracic ScNS in 8 dogs while monitoring the SGNA, vagal nerve activity (VNA) and subcutaneous nerve activity (ScNA).

  6. 1 lut 2020 · Subcutaneous Nerve Stimulation Reduces Sympathetic Nerve Activity in Ambulatory Dogs with Myocardial Infarction. February 2020. Heart Rhythm 17 (7) DOI: 10.1016/j.hrthm.2020.02.006....

  7. Objective: The purpose of this study was to test the hypothesis that chronic thoracic subcutaneous nerve stimulation (ScNS) could reduce SG nerve activity (SGNA) and control paroxysmal atrial tachycardia (PAT).

  1. Ludzie szukają również